Cash generation is inconsistent relative to earnings, with the operating cash flow to net income ratio falling to -0.59 in 2025Q4, indicating that reported profits are not reliably converting to cash.
Aegon Ltd. (AEG) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 265.25M | 891.37M | 762M | 864M | 2.85B | -1.8B | -2.85B | 7.3B | 517M | 554M | 3.31B | 914M | 4.12B | -1.73B | -966M | 2.27B | 1.26B | -7B | 1.32B | -1.36B | 7.85B | 3.6B | 8.73B | 11.26B | 16.43B | 683M | 3.02B | 21.51B | 14.59B | 9.53B | 8.43B |
| Operating CF Growth % | 178.22% | 16.98% | -11.81% | -69.69% | 258.74% | 37.07% | -139.09% | 1312.38% | -6.68% | -83.27% | 262.25% | -77.83% | 338.27% | -79.09% | -142.63% | 79.41% | 118.03% | -629.48% | 197.57% | -117.27% | 118.23% | -58.76% | -22.47% | -31.47% | 2305.12% | -77.4% | -85.95% | 47.48% | 53.09% | 13.04% | -22.65% |
| Operating CF / Revenue % | 0.54% | 3.32% | 3.9% | 6.66% | -13.17% | -3.86% | -7.02% | 11.94% | 3.55% | 1.04% | 6.67% | 2.91% | 9.38% | -3.84% | -2.25% | 7.13% | 2.57% | -15.09% | 17.58% | -2.98% | 15.93% | 7.91% | 30.61% | 39.6% | 52.75% | 2.14% | 9.83% | 96.16% | 89.78% | 67.07% | 73.74% |
| Net Income | 2.31B | 938.44M | 660M | -162M | -922M | 2.4B | -364M | 1.46B | 751M | 2.53B | 610M | -514M | 889M | 1.15B | 1.85B | 916M | 1.91B | 204M | -1.08B | 3.07B | 3.39B | 3.63B | 1.66B | 1.79B | 1.55B | 2.4B | 2.07B | 1.57B | 1.18B | 1B | 732.01M |
| Depreciation & Amortization | -242.06M | -160.41M | -31M | 34M | 1.16B | 1.17B | 722M | 1.19B | 1.31B | 781M | 1.21B | 1.52B | 971M | 1.19B | 1.44B | 1.69B | 1.64B | 1.72B | 1.69B | 1.45B | 1.92B | 1.48B | 1.74B | 1.84B | 1.95B | 1.5B | 1.34B | 939M | 771.52M | 657.05M | 409.74M |
| Stock-Based Compensation | 0 | 0 | 0 | 54M | 48M | 0 | 0 | 0 | 0 | 0 | 0 | 17M | 33M | 41M | 32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | -48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -98M | -442M | 0 | -187M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -26.01B | -6.64B | -11.97B | -9.69B | 63.45B | -12.73B | -22.96B | -24.57B | 18.86B | -13.19B | -10.31B | 5.9B | -16.92B | -17.19B | -10.69B | 6.67B | -10.44B | -22.2B | 18.72B | 6.02B | 1.76B | -19.99B | 7.13B | 12.08B | 14.2B | 2.24B | 7.53B | 22.54B | 12.16B | -9.93B | 6.02B |
| Working Capital Changes | 24.26B | 6.75B | 12.1B | 10.63B | -60.84B | 7.36B | 19.75B | 29.23B | -20.41B | 10.43B | 11.81B | -6B | 19.18B | 13.12B | 6.43B | -7.01B | 8.16B | 13.27B | -18B | -11.8B | 10.63B | 18.48B | -1.61B | -4.46B | -1.26B | -5.46B | -7.92B | -3.54B | 478.58M | 17.8B | 1.27B |
| Cash from Investing | 1.03B | 557.11M | 300M | -2B | 616M | -54M | -139M | -86M | -438M | -1.2B | -1.08B | 615M | -71M | 516M | 71M | 653M | -278M | -325M | -398M | -2.66B | -199M | -4.04B | -7.4B | -12.07B | -16.23B | -9.98B | -7.01B | -24.05B | -11.56B | -10.46B | -8.08B |
| Capital Expenditures | -107.32M | -51.87M | -51M | -116M | -98M | -112M | -120M | -148M | -123M | -101M | -88M | -142M | -92M | -73M | -86M | -90M | -101M | -212M | -97M | -85M | -72M | 0 | -245M | -97M | -162M | -194M | -159M | -101M | -79.2M | -72.63M | -54.37M |
| Acquisitions | 5.87M | -9.61M | 7M | -1.95B | 570M | -38M | -166M | -132M | -428M | -1.1B | -990M | 673M | 22M | 589M | 157M | 724M | -177M | -138M | -457M | 9M | 11M | -152M | -980M | 122M | -826M | -507M | 395M | -4.77B | 0 | 0 | 0 |
| Purchase of Investments | -107.7M | -107.58M | 0 | 0 | -130M | -98M | -305M | -269M | -146M | -121M | -112M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -375M | -67.66B | -96.59B | -100.65B | -90.06B | -61.92B | -56.46B | -26.8B | -36.5B | -25.4B |
| Sale/Maturity of Investments | 784.26M | 726.16M | 39M | 0 | 185M | 61M | 154M | 1M | 7M | 2M | 3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55.01B | 59.51B | 92.28B | 96.44B | 94.18B | 59.16B | 38.01B | 25.04B | 27.31B | 17.38B |
| Other Investing | 457.52M | 0 | 305M | 72M | 89M | 133M | 298M | 462M | 113M | 1M | 3M | 84M | -1M | 5M | 1M | 19M | -2M | 25M | 156M | -2.59B | -138M | -58.52B | 1.98B | -7.79B | -11.04B | -13.4B | -4.49B | -723M | -9.72B | -1.2B | 0 |
| Cash from Financing | -3.68B | -1.93B | -1.75B | -3.24B | -1.83B | 300M | -778M | -3.73B | -2.4B | 519M | -457M | -2.79B | 715M | -2.55B | 2.6B | -374M | 119M | 1.76B | 1.46B | -699M | -874M | -1B | 530M | 872M | 523M | 9.44B | 3.75B | 2.37B | -2.92B | 676.63M | 162.32M |
| Dividends Paid | -1.17B | -572.48M | -521M | -494M | -167M | -121M | -63M | -309M | -328M | -294M | -306M | -292M | -266M | -323M | -207M | -59M | -90M | -122M | -660M | -668M | -471M | -272M | -351M | -177M | -734M | -544M | -298M | -487M | -356.81M | -266.33M | -263.18M |
| Share Repurchases | -1.35B | -527.33M | -925M | -1.07B | -597M | -231M | -59M | -318M | -248M | -266M | -623M | -213M | -199M | -92M | 0 | 0 | 0 | 0 | -217M | -1.44B | -262.39M | 0 | 0 | 0 | -5.72M | -21.34M | -438M | -315M | -500M | 0 | 0 |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 2M | 0 | 1M | 0 | 2M | 2M | 913M | 0 | 1.01B | 0 | 1M | 264.39M | 2M | 1.37B | 19M | 5.72M | 1.69B | 7M | 686M | 15.33M | 20.23M | 13.08M |
| Debt Issuance (Net) | -4M | -1000K | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K |
| Other Financing | 22.96M | -30.74M | -63M | -76M | -75M | -203M | -115M | 1.79B | -336M | 0 | -177M | 1M | -1.38B | -60M | -502M | -1.01B | 49M | -14M | -36M | 521M | 412.11M | 521.49M | -1.47B | 0 | -7M | -42M | 3.71B | 1.89B | -633.19M | 1.04B | 386.81M |
| Net Change in Cash | 6.99B | -324.51M | -605M | -4.41B | 1.6B | -1.48B | -3.89B | 3.52B | -2.28B | -321M | 1.75B | -1.06B | 5B | -3.85B | 1.73B | 2.65B | 1.16B | -5.49B | 2.12B | -5.01B | 6.32B | -736M | 1.85B | 57.87M | 719.46M | 142.63M | -239.66M | -161.63M | 109.85M | 676.63M | 162.32M |
| Exchange Rate Effect | 1.42B | 152.87M | 88M | -38M | 55M | 67M | -121M | 33M | 35M | -196M | -23M | 200M | 231M | -79M | 27M | 107M | 57M | 81M | -265M | -288M | -458M | 708M | -6.19M | -125.6K | 462.15K | -367.57K | -656.5K | -629.02K | 0 | 927.05M | -351.43M |
| Cash at Beginning | 3.27B | 3.51B | 4.07B | 8.49B | 6.89B | 8.37B | 12.26B | 8.74B | 11.03B | 11.35B | 9.59B | 10.65B | 5.65B | 9.5B | 7.83B | 5.17B | 4.01B | 9.51B | 7.38B | 12.39B | 6.07B | 6.8B | 1.64B | 1.58B | 869.07M | 726.64M | 967.15M | 1.13B | 1.01B | 1.26B | 740.68M |
| Cash at End | 3.51B | 3.19B | 3.47B | 4.07B | 8.49B | 6.89B | 8.37B | 12.26B | 8.74B | 11.03B | 11.35B | 9.59B | 10.65B | 5.65B | 9.56B | 7.83B | 5.17B | 4.01B | 9.51B | 7.38B | 12.39B | 6.07B | 3.49B | 1.64B | 1.59B | 869.27M | 727.49M | 970.77M | 1.12B | 1.94B | 903M |
| Free Cash Flow | 173.33M | 851.99M | 711M | 799M | 2.75B | -1.91B | -2.97B | 7.15B | 394M | 453M | 3.22B | 772M | 4.03B | -1.8B | -1.05B | 2.18B | 1.16B | -7.22B | 1.23B | -1.44B | 7.78B | 3.6B | 8.48B | 11.16B | 16.27B | 489M | 2.86B | 21.41B | 14.51B | 9.46B | 8.38B |
| FCF Growth % | -55.67% | 19.83% | -11.01% | -70.98% | 244.29% | 35.84% | -141.57% | 1715.74% | -13.02% | -85.94% | 317.49% | -80.84% | 323.52% | -71.39% | -148.35% | 87.26% | 116.1% | -688.66% | 185.08% | -118.52% | 116.23% | -57.57% | -23.99% | -31.38% | 3226.18% | -82.92% | -86.63% | 47.59% | 53.43% | 12.9% | -22.8% |
| FCF Margin % | 0.35% | 3.17% | 3.64% | 6.16% | -12.72% | -4.1% | -7.32% | 11.7% | 2.71% | 0.85% | 6.5% | 2.46% | 9.17% | -4% | -2.45% | 6.85% | 2.36% | -15.55% | 16.29% | -3.16% | 15.78% | 7.91% | 29.75% | 39.26% | 52.23% | 1.53% | 9.31% | 95.7% | 89.29% | 66.56% | 73.27% |
| FCF per Share | 0.11 | 0.55 | 0.35 | 0.42 | 1.36 | -0.93 | -1.45 | 3.48 | 0.15 | 0.17 | 1.23 | 0.29 | 1.51 | -0.75 | -0.55 | 1.17 | 0.68 | -4.55 | 0.81 | -0.92 | 4.57 | 2.1 | 5.15 | 6.91 | 10.93 | 0.34 | 2.07 | 16.92 | 12.06 | 8.57 | 7.52 |
Quick answers to the most common questions about buying AEG stock.
Aegon Ltd. (AEG) generated $891.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Aegon Ltd. (AEG) generated $852.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Aegon Ltd. (AEG) spent $51.9M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Aegon Ltd. (AEG) returned $572.5M to shareholders via cash dividends and spent $527.3M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Volatile cash generation and claims exposure
Float Generation Volatile Amidst Claims Spike
Aegon's underwriting cash generation is highly erratic, with operating cash flow swinging from a $556.8M inflow in 2026Q2 to a $230.6M outflow in 2025Q4, suggesting inconsistent timing of premium collections versus claims payments that complicates liquidity forecasting.
The stark contrast between quarters, particularly the $4.7B claims outflow in 2026Q2 against a $556.8M OCF, indicates that the company's float generation is not a stable, predictable source of cash. This volatility appears to be driven by lumpy claims settlements or reinsurance recoveries, making the core insurance cash flow less reliable for funding operations or capital returns than the net income figure might suggest.
Investment Activity Signals Portfolio Rebalancing
Recent quarters show a shift from minimal investment activity to significant portfolio turnover, with 2025Q4 seeing $698.3M in sales against $94.4M in purchases, which may indicate a strategic rebalancing or liquidity generation from the general account.
The pattern of sporadic, large-scale investment sales, such as the $698.3M in 2025Q4 and $185.0M in 2022Q4, suggests the portfolio is being actively managed to generate cash, possibly to offset operating shortfalls or fund shareholder returns. This intermittent liquidation activity warrants monitoring, as it could mask underlying pressure on statutory capital if it becomes a recurring necessity rather than a tactical choice.
Shareholder Returns Outpace Cash Generation
In 2025Q4, Aegon returned $997.1M to shareholders via dividends and buybacks while generating negative operating cash flow of $230.6M, implying that capital returns were funded by portfolio liquidations or balance sheet reserves rather than core cash generation.
The sustained commitment to buybacks, totaling over $2.4B across the last four reported quarters, appears aggressive given the inconsistent operating cash flow profile. This strategy may be supported by the company's liquidity buffer or the proceeds from the Dutch divestment, but it raises questions about the long-term sustainability of returns if underwriting cash flow does not stabilize.
Cash Flow Lags Earnings, Raising Quality Concerns
The OCF-to-Net Income ratio has been negative or below 1.0 in six of the last ten quarters, including a -0.59 reading in 2025Q4, suggesting that reported earnings are frequently not translating into immediate cash generation.
This persistent disconnect, highlighted by the prior analysis of volatile earnings, indicates that non-cash items like reserve adjustments or the equity-accounted aSR stake may be inflating net income without corresponding cash inflows. Investors should scrutinize the quality of earnings, as the cash reality appears weaker than the statutory profit line, particularly in periods of negative operating cash flow.
Cash Flow Obscures CRE and Reserve Risks
The cash flow statement does not disclose the credit quality or liquidity of the US Commercial Real Estate holdings within the Transamerica general account, a known risk that could force unexpected portfolio sales or impair capital.
While the statement shows investment sales, it provides no insight into whether these are forced liquidations of impaired assets or routine rebalancing. Furthermore, the lumpy claims payments, such as the $4.7B in 2026Q2, could be masking the emergence of adverse loss trends or reserve strengthening needs that are not yet visible in the incurred loss data, creating a potential hidden liability.